This hypothesis is supported by the serum IL-1β and the serum and CSF IL-6 results, which may also explain why an increase in these factors occurred at an early stage in PSP-RS patients examined three to six years after disease initiation. The gene discussed is IL1B; the disease is X-linked retinoschisis.